HRP20060448T3 - Novi spojevi s 14 i 15-članim prstenovima - Google Patents

Novi spojevi s 14 i 15-članim prstenovima

Info

Publication number
HRP20060448T3
HRP20060448T3 HR20060448T HRP20060448T HRP20060448T3 HR P20060448 T3 HRP20060448 T3 HR P20060448T3 HR 20060448 T HR20060448 T HR 20060448T HR P20060448 T HRP20060448 T HR P20060448T HR P20060448 T3 HRP20060448 T3 HR P20060448T3
Authority
HR
Croatia
Prior art keywords
member rings
hydrogen
optionally substituted
new joints
bicyclic heteroaryl
Prior art date
Application number
HR20060448T
Other languages
English (en)
Croatian (hr)
Inventor
Alihodzic Sulejman
Keith Forrest Andrew
Lewis Jarvest Richard
Lazarevski Gorjana
Pavlovic Drazen
Original Assignee
Glaxo Group Limited
Glaxosmithkline Istrazivacki Centar Zagreb D.O.O.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Limited, Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. filed Critical Glaxo Group Limited
Publication of HRP20060448T3 publication Critical patent/HRP20060448T3/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HR20060448T 2003-05-13 2004-05-11 Novi spojevi s 14 i 15-članim prstenovima HRP20060448T3 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0310986.5A GB0310986D0 (en) 2003-05-13 2003-05-13 Novel compounds
PCT/EP2004/005082 WO2004101586A1 (en) 2003-05-13 2004-05-11 Novel 14 and 15 membered-ring compounds

Publications (1)

Publication Number Publication Date
HRP20060448T3 true HRP20060448T3 (hr) 2007-03-31

Family

ID=9957984

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20060448T HRP20060448T3 (hr) 2003-05-13 2004-05-11 Novi spojevi s 14 i 15-članim prstenovima

Country Status (22)

Country Link
US (1) US7569550B2 (enExample)
EP (1) EP1628988B1 (enExample)
JP (1) JP2007502313A (enExample)
KR (1) KR20060026407A (enExample)
CN (1) CN1849328A (enExample)
AR (1) AR044309A1 (enExample)
AT (1) ATE341560T1 (enExample)
AU (1) AU2004238528A1 (enExample)
BR (1) BRPI0410246A (enExample)
CA (1) CA2525452A1 (enExample)
CL (1) CL2004001010A1 (enExample)
DE (1) DE602004002696T2 (enExample)
DK (1) DK1628988T3 (enExample)
ES (1) ES2273255T3 (enExample)
GB (1) GB0310986D0 (enExample)
HR (1) HRP20060448T3 (enExample)
MX (1) MXPA05012163A (enExample)
PL (1) PL1628988T3 (enExample)
PT (1) PT1628988E (enExample)
RU (1) RU2005134908A (enExample)
WO (1) WO2004101586A1 (enExample)
ZA (1) ZA200509079B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0424958D0 (en) * 2004-11-11 2004-12-15 Glaxo Group Ltd Novel compounds
WO2007054295A1 (en) * 2005-11-09 2007-05-18 Glaxo Group Limited New 4*-substituted erythromycin derivative
GB0424961D0 (en) * 2004-11-11 2004-12-15 Glaxo Group Ltd Novel compounds
DE602006015919D1 (de) * 2005-01-13 2010-09-16 Glaxosmithkline Zagreb Makrolide mit entzündungshemmender wirkung
JP2008540503A (ja) 2005-05-10 2008-11-20 グラクソスミスクライン・イストラジヴァッキ・センタル・ザグレブ・ドルズバ・ゼー・オメイェノ・オドゴヴォルノスティオ 細菌感染症の処置に有用なエーテル結合マクロライド
WO2007054296A1 (en) * 2005-11-09 2007-05-18 Glaxo Group Limited Macrolones
JP5437394B2 (ja) 2009-01-30 2014-03-12 グラクソ グループ リミテッド 抗炎症性マクロライド
CN111574575B (zh) * 2020-04-29 2022-05-17 北京理工大学 一种含有大环内酯基的喹喏酮衍生物、制备方法及应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL93936A (en) * 1989-03-28 1994-06-24 Abbott Lab History of 9-dioxo-21,9-epoxy - erythromycin, method of preparation History of 11-oxo and 11-hydroxy, and pharmaceutical preparations containing them
WO1996034007A1 (es) * 1995-04-27 1996-10-31 Laboratorios Aranda, S.A. De C.V. Derivados de quinolonilcarboxieritromicina y composiciones farmaceuticas que los contienen
DE69723848T2 (de) * 1996-05-07 2004-07-01 Abbott Laboratories, Abbott Park 3-descladinose-2,3-anhydroerythromycin-derivate
GB0025688D0 (en) * 2000-10-19 2000-12-06 Glaxo Group Ltd Macrolides
JP4311203B2 (ja) * 2001-08-08 2009-08-12 大正製薬株式会社 １１ａ−アザライド化合物及びその製造方法
GB0127349D0 (en) 2001-11-14 2002-01-02 Glaxo Group Ltd Macrolides

Also Published As

Publication number Publication date
PL1628988T3 (pl) 2007-03-30
GB0310986D0 (en) 2003-06-18
WO2004101586A1 (en) 2004-11-25
CA2525452A1 (en) 2004-11-25
US7569550B2 (en) 2009-08-04
RU2005134908A (ru) 2006-06-27
DK1628988T3 (da) 2007-02-05
AR044309A1 (es) 2005-09-07
ZA200509079B (en) 2007-02-28
JP2007502313A (ja) 2007-02-08
MXPA05012163A (es) 2006-05-19
AU2004238528A1 (en) 2004-11-25
CL2004001010A1 (es) 2005-03-18
DE602004002696D1 (de) 2006-11-16
KR20060026407A (ko) 2006-03-23
EP1628988A1 (en) 2006-03-01
ATE341560T1 (de) 2006-10-15
CN1849328A (zh) 2006-10-18
US20070185117A1 (en) 2007-08-09
BRPI0410246A (pt) 2006-05-16
EP1628988B1 (en) 2006-10-04
PT1628988E (pt) 2007-01-31
ES2273255T3 (es) 2007-05-01
DE602004002696T2 (de) 2007-08-16

Similar Documents

Publication Publication Date Title
HRP20030003B1 (en) N-oxides as nk1 receptor antagonist prodrugs of 4-phenyl-pyridine derivatives
CO4960662A1 (es) Ciertos acidos 5-alquil-2-arilaminofenilaceticos y sus derivados
HRP20090162T1 (en) Quinolinone-carboxamide compounds as 5-ht4 receptor agonists
PE20030762A1 (es) Compuestos heterociclicos como antagonistas nk1
SE0000540D0 (sv) New compounds
BR0109991A (pt) Composição farmacêutica
EA200000155A3 (ru) 4-фенилпиридиновые производные
DE60336850D1 (en) Substituierte arylcyclopropylacetamide als glucokinaseaktivatoren
ES2008359A6 (es) Procedimiento para preparar nuevos derivados de catecol farmacologicamente activos.
CO6270328A2 (es) Derivados de pirrolo [2,3] pirimidina como inhibidores de proteinas quinasas b
ECSP066967A (es) Derivados de tetrahidroquinolina y un procedimiento para preparar los mismos
ATE297910T1 (de) Retinoid x rezeptormodulatoren
YU68896A (sh) Jedinjenja hinolina i nihazolina od koristi u terapiji
EA200300558A1 (ru) Агонисты альфа-рецепторов, активируемых пролифератором пероксисомы
AR041395A1 (es) Compuesto de piridina composicion farmaceutica que lo comprende y su uso para prepararla
ATE155133T1 (de) Piperazinderivate als 5-ht antagonisten
MX2023001803A (es) Derivados de 2,4-diaminoquinazolina y usos medicos de los mismos.
DE69507293D1 (de) Benzamid-derivate als vasopressin-antagonisten
BRPI0621693B8 (pt) compostos derivados de benzotiazinona, composição farmacêutica, e seu uso como agentes antibacterianos
CY1110392T1 (el) Υποκατεστημενα παραγωγα μορφολινης και θειομορφολινης
AR058701A1 (es) Derivados de piracinil-s-espiro-oxacinoquinolin-pirimidin-triona como agentes antibacterianos
DK1181294T3 (da) Hidtil ukendte derivater og analoger af galanthamin
DE60327922D1 (de) Harnstoff-linker verbindungen und ihre verwendung als ppar regulatoren
CO5690593A2 (es) Nuevos derivados de pirimidin 2-amina
HRP20070529T3 (hr) Derivati imidazola kao antagonisti receptora glutamata